Literature DB >> 3328680

Low-dose fentanyl analgesia modified by calcium channel blockers in cardiac surgery.

J Boldt1, B von Bormann, D Kling, W Russ, K Ratthey, G Hempelmann.   

Abstract

The hypothesis that calcium channel blockers can potentiate and prolong the anti-nociceptive effects of opioids was tested. Forty-five men scheduled for aorto-coronary bypass operation received fentanyl according to their individual demands (haemodynamics, clinical parameters). The patients were allocated at random into three groups receiving either nimodipine 1.0 microgram kg-1 min-1 (Group 1, n = 15), nifedipine 0.70 microgram kg-1 min-1 (Group 2, n = 15), or no calcium channel blocker (Group 3, n = 15). Cerebral activity was monitored using a computerized spectral analysing system before and during the operation. The total amount of fentanyl required was significantly lower in the nimodipine group than the control group (-71%, P less than 0.001), whereas the nifedipine group did not differ from the control group. Quality of intra-operative anaesthesia was comparable in the three groups with respect to clinical observations (amnesia, sweat, tears, pupils), and the post-operative course was similar in all patients as well. Cerebral activity during the nimodipine-supplemented opioid anaesthesia was higher in the faster frequency bands (13-30 Hz). Power level in the beta range was most pronounced in Group 1, whereas power in the alpha range was similar in the calcium channel-blocker groups. The major conclusion was that nimodipine but not nifedipine administration can reduce fentanyl requirements during surgical procedures without influencing the quality of anaesthesia.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3328680

Source DB:  PubMed          Journal:  Eur J Anaesthesiol        ISSN: 0265-0215            Impact factor:   4.330


  1 in total

1.  Potentiation of acute opioid-induced respiratory depression and reversal of tolerance by the calcium antagonist nimodipine in awake rats.

Authors:  F Ruiz; M Dierssen; J Flórez; M A Hurlé
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-12       Impact factor: 3.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.